$CVM CEL-SCI Corporation (NYSE American: CVM) is a clinical-stage biotechnology company based in Vienna, Virginia, focused on developing immunotherapy treatments for cancer, autoimmune, and infectious diseases. More research opinion
https://cel-sci.com/about-us/